P02.01 MRI ASSESSMENT OF TUMOR SIZE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED WITH DENDRITIC CELL IMMUNOTHERAPY

Por Cuccarini, V., Schettino, C., Acquino, D., Scotti, A., Cuppini, L., Finocchiaro, G., Bruzzone, M., Eoli, M.
Publicado em 2014

Relationships between Regional Radiation Doses and Cognitive Decline in Children Treated with Cranio-Spinal Irradiation for Posterior Fossa Tumors

Por Doger de Speville, Elodie, Robert, Charlotte, Perez-Guevara, Martin, Grigis, Antoine, Bolle, Stephanie, Pinaud, Clemence, Dufour, Christelle, Beaudré, Anne, Kieffer, Virginie, Longaud, Audrey, Grill, Jacques, Valteau-Couanet, Dominique, Deutsch, Eric, Lefkopoulos, Dimitri, Chiron, Catherine, Hertz-Pannier, Lucie, Noulhiane, Marion
Publicado no Front Oncol (2017)

P04.02 Analysis of 18F-DOPA PET imaging for target volume definition in patients with recurrent glioblastoma treated with proton therapy

Por Amelio, D., Scartoni, D., Palucci, A., Vennarini, S., Giacomelli, I., Lemoine, S., Donner, D., Farace, P., Chierichetti, F., Amichetti, M.
Publicado no Neuro Oncol (2017)

Pediatric lung adenocarcinoma presenting with brain metastasis: a case report

Por Lucia De Martino, Maria Elena Errico, Serena Ruotolo, Daniele Cascone, Stefano Chiaravalli, Paola Collini, Andrea Ferrari, Paolo Muto, Giuseppe Cinalli, Lucia Quaglietta
Publicado em 2018-09-01

Functional and morphological effects of diazepam and midazolam on tumor vasculature in the 9L gliosarcoma brain tumor model using dynamic susceptibility contrast MRI: a comparative study

Por Yan, Nuo, Zheng, Yuzhen, Yang, Cheng
Publicado no Drug Des Devel Ther (2017)

A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors

Por Lim, Kah Jing, Bisht, Savita, Bar, Eli E, Maitra, Anirban, Eberhart, Charles G
Publicado em 2011

Three Paths to Better Tyrosine Kinase Inhibition Behind the Blood-Brain Barrier in Treating Chronic Myelogenous Leukemia and Glioblastoma with Imatinib

Por Kast, Richard E, Focosi, Daniele
Publicado em 2010

Targeted Approaches Applied to Uncommon Diseases: A Case of Salivary Duct Carcinoma Metastatic to the Brain Treated with the Multikinase Inhibitor Neratinib

Por Sorenson, Karl R., Piovezani Ramos, Guilherme, Villasboas Bisneto, Jose Caetano, Price, Katharine
Publicado no Case Rep Oncol (2017)

QOL-47. ApoE4 AS A GENETIC PREDICTOR FOR NEUROCOGNITIVE OUTCOMES IN PEDIATRIC BRAIN TUMOR SURVIVORS

Por Kline, Cassie, Felton, Erin, Byer, Lennox, Stoller, Schuyler, Torkildson, Joseph, Gauvain, Karen, Samuel, David, Tong, Elizabeth, Liu, John, Fullerton, Heather, Dubal, Dena, Mueller, Sabine
Publicado no Neuro Oncol (2018)

IMMU-21. TARGETING EGFR IN HYPOMUTATED PEDIATRIC BRAIN TUMORS USING THE D2C7 IMMUNOTOXIN

Por Landi, Daniel, Thompson, Eric, McLendon, Roger, Desjardins, Annick, Chandramohan, Vidya, Ashley, David, Bigner, Darell
Publicado no Neuro Oncol (2018)

STEM-22. UPTAKE OF P-BORONO-PHENYLALANINE BY BRAIN TUMOR STEM LIKE CELLS ANALYZED BY MASS CYTOMETRY

Por Kondo, Natsuko, HIkida, Masaki, Nakada, Mitsutoshi, Suzuki, Minoru
Publicado no Neuro Oncol (2018)

Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?

Por Wang, Tony J. C., Saad, Shumaila, Qureshi, Yasir H., Jani, Ashish, Nanda, Tavish, Yaeh, Andrew M., Rozenblat, Tzlil, Sisti, Michael B., Bruce, Jeffrey N., McKhann, Guy M., Lesser, Jeraldine, Halmos, Balazs, Stoopler, Mark B., Lassman, Andrew B., Cheng, Simon K., Isaacson, Steven R.
Publicado no Neuro Oncol (2015)

Myeloablative Temozolomide Enhances CD8(+) T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice

Por Sanchez-Perez, Luis A., Choi, Bryan D., Archer, Gary E., Cui, Xiuyu, Flores, Catherine, Johnson, Laura A., Schmittling, Robert J., Snyder, David, Herndon, James E., Bigner, Darell D., Mitchell, Duane A., Sampson, John H.
Publicado em 2013

Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models

Por Hu, Jinwei, Ljubimova, Julia Y., Inoue, Satoshi, Konda, Bindu, Patil, Rameshwar, Ding, Hui, Espinoza, Andres, Wawrowsky, Kolja A., Patil, Chirag, Ljubimov, Alexander V., Black, Keith L.
Publicado em 2010

Intensity Modulated Radiation Therapy with Dose-painting: A Brain-sparing Technique for Intracranial Germ Cell Tumors

Por Yang, Joanna C., Terezakis, Stephanie A., Dunkel, Ira J., Gilheeney, Stephen W., Wolden, Suzanne L.
Publicado no Pediatr Blood Cancer (2015)

Establishing standard performance measures for adult brain tumor patients: a nationwide inpatient sample database study

Por Rahman, Maryam, Neal, Dan, Fargen, Kyle M., Hoh, Brian L.
Publicado em 2013

microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis

Por Bhere, Deepak, Tamura, Kaoru, Wakimoto, Hiroaki, Choi, Sung Hugh, Purow, Benjamin, Debatisse, Jeremy, Shah, Khalid
Publicado no Neuro Oncol (2018)

A co-culture model with brain tumor-specific bioluminescence demonstrates astrocyte-induced drug resistance in glioblastoma

Por Yang, Ning, Yan, Tao, Zhu, Huaiyang, Liang, Xiao, Leiss, Lina, Sakariassen, Per Øystein, Skaftnesmo, Kai Ove, Huang, Bin, Costea, Daniela Elena, Enger, Per Øyvind, Li, Xingang, Wang, Jian
Publicado em 2014

Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases

Por Li, Yingmei, Pan, Wenying, Connolly, Ian D., Reddy, Sunil, Nagpal, Seema, Quake, Stephen, Gephart, Melanie Hayden
Publicado no J Neurooncol (2016)

Complement Depletion Facilitates the Infection of Multiple Brain Tumors by an Intravascular, Replication-Conditional Herpes Simplex Virus Mutant

Por Ikeda, Keiro, Wakimoto, Hiroaki, Ichikawa, Tomotsugu, Jhung, Sarah, Hochberg, Fred H., Louis, David N., Chiocca, E. Antonio
Publicado em 2000